N/A
Completed N=30
Collaboration Live
Pregnancy Related
Source: ClinicalTrials.gov NCT04243369 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: Rate of Clinically Acceptable Performance of Remote Control Functionality — 100 Percentage of total exams
Summary
Collaboration Live is a prospective, single-arm clinical study of subjects who provide written consent. Subjects are scanned using a Philips EPIQ 5 or EPIQ 7 Ultrasound System equipped with Collaboration Live software. The study investigator will evaluate performance of the Collaboration Live tool with regard to performance of conferencing, sharing and control capabilities. Adverse events will be reported and the study investigator will assess potential relationship to the study device or study procedure. Additionally, the utility of Collaboration Live in remote consult of study patients will be evaluated. No patient follow-up beyond the initial consultation will be conducted with the Collaboration Live software solution.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Clinically Acceptable Performance of Remote Control Functionality |
100 | — |
| SECONDARY Number of Participants With Technical Issues |
2 | — |
| SECONDARY Success Rates for Key Tasks in the Collaborative Exam |
100 | — |
| SECONDARY Travel Reduction Attributable to Use of Collaboration Live |
38.0 | — |
| SECONDARY Ease of Use |
26; 4; 28; 2 | — |
| SECONDARY User Feedback Regarding Streaming, Image Quality and Overall Experience |
0; 3; 27; 1; 4; 25 | — |
| SECONDARY Patient Feedback Regarding Remote Consultation |
0; 30 | — |
| SECONDARY Impact of Remote Consultation on Reimbursement |
96.9 | — |
Eligibility Criteria
Inclusion Criteria
- Subject is at least 18 years of age
- Subject in indicated for a routine Obstetrics/Gynecology ultrasound examination at the site.
- Subject is willing and capable of providing informed consent and participating in this study
Exclusion Criteria
- A medical condition or co-morbidity that would be unduly affected by study participation, per investigator discretion
Data sourced from ClinicalTrials.gov (NCT04243369). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.